SNPMiner Trials by Shray Alag


SNPMiner SNPMiner Trials (Home Page)


Report for Clinical Trial NCT00092404

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

A Comparison of the Safety, Tolerability, and Immunogenicity of V205C Manufactured With Recombinant Human Albumin (rHA) Versus V205C Manufactured With Pooled-Donor Human Serum Albumin (HSA) in Healthy Children 12 to 18 Months of Age

The purpose of this trial is to study the safety and immune response to measles, mumps, and rubella in children who were vaccinated with an investigational measles-mumps-rubella live vaccine made with artificially made human protein.

NCT00092404 Measles Mumps Rubella Varicella
MeSH: Rubella

2 Interventions

Name: measles, mumps, and rubella virus vaccine live

Type: Biological

Name: Comparator: Measles, Mumps, and Rubella Virus Vaccine Live

Type: Biological


Primary Outcomes

Measure: Antibody response rates to measles, mumps, and rubella at 6 weeks postvaccination

Time: 6 weeks postvaccination

Secondary Outcomes

Measure: Geometric mean titers to measles, mumps, and rubella by ELISA at 6 weeks postvaccination

Time: 6 weeks postvaccination

Purpose: Prevention

Allocation: Randomized

Parallel Assignment


There is one SNP

SNPs


1 V205C

A Comparison of the Safety, Tolerability, and Immunogenicity of V205C Manufactured With Recombinant Human Albumin (rHA) Versus V205C Manufactured With Pooled-Donor Human Serum Albumin (HSA) in Healthy Children 12 to 18 Months of Age. --- V205C ---

A Comparison of the Safety, Tolerability, and Immunogenicity of V205C Manufactured With Recombinant Human Albumin (rHA) Versus V205C Manufactured With Pooled-Donor Human Serum Albumin (HSA) in Healthy Children 12 to 18 Months of Age. --- V205C --- --- V205C ---

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED) The purpose of this trial is to study the safety and immune response to measles, mumps, and rubella in children who were vaccinated with an investigational measles-mumps-rubella live vaccine made with artificially made human protein. --- V205C ---



HPO Nodes